Friday, March 17, 2017 5:02:45 PM
To a_xxxxx@yahoo.com
Friday, March 17, 2017 4:24 PM
Click to View Full HTML
Aaron
Thank you very much for your confidence and for your support. I will pass on your suggestions to Dr Okito. Please stay tuned to news and updates from the company as developments unfold.
Thanks
Investor Relations
(310) 734 6111
On Fri, 17 Mar, 2017 at 1:52 PM, aaronxxxxx <a_xxxxx@yahoo.com> wrote:
To: info@viadermalicensing.com
Hello,
I'm currently a ViaDerma investor, owning shares in the hundreds of thousands. Recently the stock price has been in free fall, making some investors very unsteady. Personally I have all the faith in Dr. Okito as well as the company, however I have seen other good, large investors selling their stake in our future do to the lack of resolution on their concerns and continuing drop of PPS.
Just an idea I would lad lke to propose, perhaps the Doctor could schedule an investors conference call following DFCON, so he can address concerns, patent issues, etc and fill us in not only on the conference he attended, but how the rollout is coming, and our future direction.
Thank you,
Aaron xxxxxx
.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM